Endometriosis and adenomyosis are complex gynecological conditions that significantly impact women’s health, quality of life, and reproductive function. Growing understanding of their pathogenic mechanisms, alongside the evolution of diagnostic and therapeutic techniques, necessitates continuous professional updating and an increasingly personalized, multidisciplinary approach.

The Congress will address key aspects of adenomyosis, ranging from its pathogenesis and the characterization of its various phenotypes to diagnosis via imaging, as well as medical and minimally invasive therapeutic strategies. Particular attention will be devoted to the relationship between adenomyosis, endometriosis, and fertility, to reproductive and obstetric outcomes, and to the management of patients undergoing medically assisted reproduction.

Significant attention will also be devoted to endometriosis, with an in-depth look at the latest developments in the understanding of the disease, medical therapies, and the evolution of minimally invasive surgery. Topics to be discussed include the role of surgery in infertile patients, fertility preservation, the management of postoperative pain, nerve-sparing surgery, and the delicate balance between treatment efficacy and the protection of reproductive function.

The goal of the Congress is to foster discussion among specialists and facilitate the sharing of the latest scientific evidence, promoting an integrated approach to the diagnosis and treatment of endometriosis and adenomyosis—an approach focused on personalizing care and safeguarding women’s health and reproductive function.